Navigation Links
Orchid Cellmark Reports Third Quarter 2008 Financial Results
Date:11/18/2008

anagement capabilities in the U.K. will influence revenue and gross margin in the fourth quarter. However, we believe the fundamentals of our core business are sound; we have achieved efficiencies in our operations; and we have a strong balance sheet with $15.9 million in cash at the end of the quarter. The DNA identity testing market offers growth opportunities with market dynamics favorable in the U.S. and a changing market in the U.K. that affords us good prospects for gaining market share."

Conference Call Information

A conference call with Orchid Cellmark management will be held on Thursday, October 30, 2008 at 10:00 a.m. EDT. To listen to the conference call, please dial (877) 266-0703 or (706) 643-7682 and ask for the Orchid Cellmark conference call, conference number 70588526. To listen to the live or archived webcast via the Internet, please visit the Investors section of the company's web site at www.orchidcellmark.com. The webcast will be available for replay for 90 days after the conference call.

About Orchid Cellmark

Orchid Cellmark (Nasdaq: ORCH) is a leading international provider of DNA testing services primarily for forensic and family relationship applications. Orchid Cellmark is one of the largest providers of forensic DNA testing services and its DNA results are used by the criminal justice system to assist with the identification of perpetrators, the exclusion of suspects and the exoneration of wrongfully convicted individuals. The company provides DNA family relationship testing to numerous child services organizations and individuals seeking to verify parentage. Orchid Cellmark also serves immigration and security authorities for DNA testing of individuals. In the agriculture field, the company provides DNA t
'/>"/>

SOURCE Orchid Cellmark Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Saving the wild orchids of Borneo
2. Orchid Cellmark to Present at the 2008 Bank of America Health Care Conference
3. First orchid fossil puts showy blooms at some 80 million years old
4. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
5. Synaptics Reports Record Results for First Quarter of Fiscal 2009
6. GEN reports on novel tools for deciphering biological networks
7. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
8. LSUHSC research reports new method to protect brain cells from diseases like Alzheimers
9. Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results
10. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
11. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...RNewswire/ -- Global Rainmakers, Inc., an intellec... laboratory, today announced that the company has ...ely commercialize its suite of technologies design...erings. ,, During the past four years, the comp...op and deploy a series of core--but expandable--te...
(Date:11/3/2009)..., 2009 -- The world,s greatest wines are the resu...an input, and something called the "terroir" -- a ... climate. , Experts will discuss terroir with ...esday, Nov. 4 in Pittsburgh. "Terroir: Winegrapes...ts at the 2009 Annual Meetings of the American Soc...
(Date:11/3/2009)... labeling of fruit and vegetables is a new, patent... laser beam is used to label, or "etch" informatio...mon sticker-type labels. The technology has been l...les and is being used in New Zealand, Australia, a...d in Asia, South Africa, Central and South America...
Breaking Biology News(10 mins):Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Great wines come from great soils 2Laser etching safe alternative for labeling grapefruit 2Netsmart Technologies Ranked in Healthcare Informatics Top 100 51228 1Netsmart Technologies Ranked in Healthcare Informatics Top 100 51228 2Alzheimers Foundation of America and Samarion 28SM 29 Form Strategic Alliance to Enhance Care for Individuals with Dementia 51224 1Alzheimers Foundation of America and Samarion 28SM 29 Form Strategic Alliance to Enhance Care for Individuals with Dementia 51224 2Alzheimers Foundation of America and Samarion 28SM 29 Form Strategic Alliance to Enhance Care for Individuals with Dementia 51224 3Business Opportunities in Spains Fast Growing Biotechnology Industry 12960 1Business Opportunities in Spains Fast Growing Biotechnology Industry 12960 2
... (BRONX, NY) Researchers from the Albert Einstein...rgh have developed an onsite method to quickly dia...-resistant strains that can mingle undetected with...ed in PLoS ONE , a peer-reviewed online journal f...ers engineered bacteriophages, tiny viruses that a...
...ed deaths in England and Wales are twice as high a...ith the rest of the population, a study has shown....urgh and the Office for National Statistics, also ...d and Wales had similar rates of alcohol-related ...indings showed too that people born in parts of As...
...the University of Bath are to be part of a 3 milli...esearch into safer, more effective anti-bacterial ...ch as food packaging, medical devices to wound dre...d a range of new compounds which have been shown t...erial infections such as MRSA and are safer than e...
Other Biology News:Einstein and Pitt researchers develop new TB test that will dramatically cut diagnosis time 2Scots and Irish at greater risk of drink-related death, study shows 2University researchers to develop coatings that kill superbugs 2
(Date:11/6/2009)...,, QUINCY, Mass., Nov. 6 Myrian...biotech developer and manufacturer of renewable b...preferred technology provider Uhde GmbH, one of th... "Uhde"), announced an alliance for the engineerin...,s biobased Succinic Acid plants based on renewabl...
(Date:11/6/2009)...,, CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Onc...lytics" or the "Company") today announced updated ...SIN(R) in patients with sarcomas metastatic to the...Connective Tissue Oncology Society Meeting held in...he poster presentation, entitled "A Phase II Study...
(Date:11/5/2009)...,, GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstC...ced its financial results for the third quarter en... of $3.6 million ($0.04 per share) for the three m...oss of $6.8 million ($0.08 per share) in the compa...eptember 30, 2009, GenVec,s net loss was $14.1 mil...
(Date:11/5/2009)...,, RANCHO CORDOVA, Calif., Nov. 5 /PRNewswire-F... a leading supplier of innovative products for pro...ed results for the first quarter of fiscal 2010. ,... Company reported revenues of $5.2 million, a 15 p...he first quarter a year ago. The Company said the ...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...any, February 4 , - Sales up by 48% at EUR958 Mil... Another Acquisition in the Target Segment of Phar...rket Leader for Pharma Plastic Taken Over, Accord...st completed,another record year. In 2007 the comp...adjusted Group EBITDA margin reached 19%. "This gr...
.... (Thursday, Jan. 31, 2008) -- A University of Wat...per to be published Friday in Science Magazine, sh...oscale. , The UW researchers, professor James For...e a major step forward in discovering how to measu..., They explore the properties of the large class ...
...Feb. 1 Watson,Pharmaceuticals, Inc. (NYSE: WPI )...unced today that Paul Bisaro, Watson,s president a...ew and update of the Company,s,business at the 200...gy and,Medical Device Conference on Tuesday, Febru...This presentation will be webcast live and can be ...
Other Biology Technology:2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer 22007 Another Record Year in Terms of Sales and Earnings for Gerresheimer 3UW paper in Science shows how some solids mimic liquids on nanoscale 2
BLOCK-iT siRNA, Stealth and Custom RNA from Invitrogen
...atoms at the 9, 10, 12, and 13 positions. It is in...ntification of 13(S)-HODE by GC- or LC-mass spectr...noleic acid with plant and mammalian lipoxygenases...or cells to the endothelium at concentrations arou...
Adaptor BamH I-Sma I from Takara Mirus Bio
Cassette, Hind III from Takara Mirus Bio
Biology Products: